Showing results (251-260 of 443) with videos related to
Sort By:
Pageof 45
Mabs|August 7, 2012
2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USAMitchell Ho, Ivor Royston, Alain BeckClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2011
Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hostsMiriam E Mossoba, Masanori Onda, Justin Taylor, et al.Toxins|November 10, 2011
Imaging of convection enhanced delivery of toxins in humansAnkit I Mehta, Bryan D Choi, Raghu Raghavan, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|February 20, 2016
Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for ImmunotherapyPeter B Illei, Christine Alewine, Marianna Zahurak, et al.Pediatric Blood & Cancer|March 3, 2015
Characterization of CD22 expression in acute lymphoblastic leukemiaNirali N Shah, Maryalice Stetler Stevenson, Constance M Yuan, et al.Journal of Neuro-Oncology|November 10, 2009
Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1Dale Ding, Charles W Kanaly, Darrell D Bigner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38Sufi M Thomas, Qing Zeng, Michael W Epperly, et al.Proceedings of the National Academy of Sciences of the United States of America|January 10, 2018
Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicityRonit Mazor, Emily M King, Masanori Onda, et al.Journal of Leukocyte Biology|August 23, 2006
Anti-HIV-1 immunotoxin 3B3(Fv)-PE38: enhanced potency against clinical isolates in human PBMCs and macrophages, and negligible hepatotoxicity in macaquesPaul E Kennedy, Tapan K Bera, Qing-Cheng Wang, et al.Oncology Letters|June 17, 2014
TGFα-PE38 enhances cytotoxic T-lymphocyte killing of breast cancer cellsStephen E Wright, Kathleen A Rewers-Felkins, Imelda Quinlin, et al.Pageof 45